Your new experience awaits. Try the new design now and help us make it even better

RETRACTION article

Front. Pharmacol., 16 January 2026

Sec. Pharmacology of Anti-Cancer Drugs

Volume 17 - 2026 | https://doi.org/10.3389/fphar.2026.1781973

Retraction: Corrigendum: AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-Catenin signaling pathway in triple-negative breast cancer

This article is a retraction of:

  1. RETRACTED: Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Correction Article
Corrigendum: AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-Catenin signaling pathway in triple-negative breast cancer

by Zhang K, Liu P, Tang H, Xie X, Kong Y, Song C, Qiu X and Xiao X (2020) Front. Pharmacol. 11:1107. doi: 10.3389/fphar.2020.01107

The journal retracts the 20 July 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Frontiers would like to thank Kevin Patrick for contacting the journal regarding the published article.

Citation: Frontiers Editorial Office (2026) Retraction: Corrigendum: AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-Catenin signaling pathway in triple-negative breast cancer. Front. Pharmacol. 17:1781973. doi: 10.3389/fphar.2026.1781973

Received: 06 January 2026; Accepted: 06 January 2026;
Published: 16 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.